Baylor University Medical Center - Houston
One Baylor Plaza
Houston, Texas 77030
(713) 798-4951 https://www.bcm.edu

Use our guide to learn which trials are right for you!

Baylor University Medical Center in Dallas began in 1903 as Good Samaritan Hospital, a two-story brick house converted into a private hospital. A year later, after being purchased by the Baptist General Convention of Texas, the hospital became Texas Baptist Memorial Sanitarium. Fifty-five years later, that institution became Baylor University Medical Center. BUMC comprises five connecting patient hospitals and a cancer center; Baylor is the second largest nonprofit private hospital in the United States. The center, licensed for 1,509 beds, treated 408,581 patients in fiscal 1992. As a major referral center, it offers specialized treatment centers for cancer, heart disease, diabetes, digestive diseases, alcohol and drug abuse, psoriasis, asthma, hair loss, breast disease, eating disorders, neonatology, pediatrics, infectious diseases, and weight management.

Baylor University Medical Center is the hub of the Baylor Health Care System, a nonprofit network founded in 1981. The system comprises five North Texas hospitals: Baylor University Medical Center, Baylor Institute for Rehabilitation, and Baylor Medical centers at Ennis, Garland, Grapevine, and Waxahachie.

We've found
5 trials
at this facility
Oncology Clinical Trial
Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Status: Enrolling
Updated: 10/11/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling, Phase I
Updated: 10/11/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Status: Enrolling
Updated: 7/12/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Enrolling
Updated: 10/11/2012
mi
from
Houston, TX
Click here to add this to my saved trials